No Detail Found!

Evaluation of efficacy of serological methods for detection of HCV infection in blood donors: A single centre experience.

Author(s)
Arshi Naz National Institute of Blood Diseases & Bone Marrow Transplantation,Karachi, Pakistan.
Samina Naz Mukry National Institute of Blood Diseases & Bone Marrow Transplantation,Karachi, Pakistan.
Imran Naseer National Institute of Blood Diseases & Bone Marrow Transplantation,Karachi, Pakistan.
Tahir Sultan Shamsi National Institute of Blood Diseases & Bone Marrow Transplantation,Karachi, Pakistan.
Abstract
Blood transfusion is an essential and life-saving medical intervention. Despite multiple preventive measures transfusion-transmitted hepatitis C virus (HCV) infection continues to be a major healthcare issue in Pakistan. This study was conducted at National Institute of Blood Diseases & Bone Marrow Transplantation to evaluate the frequency of active HCV infection with or without co-infection in blood donors and also to determine comparative efficacy of Multisure HCV antibody assay (MHAA); a new serological device. Methods: A total of 14652 blood donors visiting National Institute of Blood Diseases & Bone Marrow Transplantation (NIBD) Blood Bank from January 2013 to July 2014 were enrolled and screened for a range of blood borne infections such as HBV, HCV, HIV, malaria and syphilis. The HCV was screened simultaneously by Abbot Architect anti-HCV assay (CLIA) and MHAA. The active HCV infection was confirmed by nucleic acid testing (NAT) in reactive donors. Later; for determination of comparative efficacy of MHAA; all NAT positive samples were further tested using MonolisaTM, HCV blot 3.0, Anti-HCV plus V2 and Anti-HCVMPBIO-EIA. Results: The HCV reactive sera were observed in 1.563% (226) donors. The NAT confirmed active HCV infection in 138 donors. Overall 27.84% of HCV positive donors exhibited coinfection either with HBV (2.57%), syphilis (22.78%). Triple infection was not observed in any donor. The efficacy of MHAA is comparable to all the serological tests with a sensitivity of about 96.89%. Conclusion: Active HCV infection was present in 0.94% donors. With a sensitivity of 96.89% (95% CI: 95.6698.12) the multi-parametric device MHAA can effectively detect HCV infection in donors. Thus, it can be used in limited health care settings for HCV screening.
Publication Details
Page(s) 1204-1208
DOI DOI not available
Published Journal: Pakistan Journal of Medical Sciences, Volume: 34, Issue: 5, Year: 2018

Request the full text from PASTIC

Keywords
Blood donors, Active HCV infection
0

Citations

0

Downloads

98

Views